| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | 0.1 | 0.001 |
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | 0.17 | 0.001 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | 0.095 | 0.002 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.002 |
| mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | 0.086 | 0.002 |
| mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.18 | 0.002 |